Mutation in collagen gene induces cardiomyopathy in transgenic mice

Journal of Cellular Biochemistry

Volumn 85, Issue 2, 2002, Pages 259-267

  Miller, Amanda D ^a   Tyagi, Suresh C ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Cardiac ring; Disintegrin metalloproteinase; ECG; Elastin; Fibrosis; Functional genomic; Gelatinase; Gene expression; Heart failure; LVH

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 1; GELATINASE A; INTEGRIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA PRESSURE; APOPTOSIS; ARTICLE; BINDING SITE; CARDIOMYOPATHY; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE MUTATION; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; TRANSGENIC MOUSE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CARDIOMYOPATHIES; COLLAGEN; ELASTIN; ELECTROCARDIOGRAPHY; FEMALE; HEART INJURIES; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NOREPINEPHRINE; TISSUE INHIBITOR OF METALLOPROTEINASES; VENTRICULAR FUNCTION, LEFT;

MUS MUSCULUS;

EID: 0036212542     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10130     Document Type: Article

References (34)

1. MMP-2 is an interstitial collagenase
2. Autosomal dominant marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes
3. Comparative stability of physiological parameters during sustained anesthesia in rats
4. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, marfan syndrome, and the long QT syndrome
5. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene
6. SVAS associated with a deletion disrupting the elastin gene
7. Wall stress and patterns of hypertrophy in the human left ventricle
8. Dietary lipid modulation of connective tissue matrix in rat abdominal aorta
9. The cardiomyopathies
10. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertropy and selective diastolic dysfunction in transgenic mice
11. Expression of MMP-2 and -9 in regerating skeletal muscle, a study in experimentally injured and mdx muscles
12. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling
13. Chaos theory, heart rate variability, and arrhythmic mortality
14. Transition from hypertrophy to heart failure
15. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute workshop)
16. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility
17. Temporal regulation of ECM components in transition from compensatory hypertrophy to decompensatory heart failure
18. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrohic cardiormyopathy
19. Supravalvular aortic stenosis
20. Role of the extracellular matrix in X-chromosome-linked musclular dystrophy: Immunohistochemical study
21. Human 92- and 72-kilodalton type IV collagenases are elastases
22. Cysteine and metalloproteinase activity in serum of Duchenne muscular dystrophic genotype
23. Progression of cardiac involvement in patients with myotonic dystrophy, muscular dystrophy and mitochondrial myopathy during a 2-year follow up
24. Alpha-tropomyosin and cardiac troponin T mutations cause falilial hypertrophic cardiomyopathy: A disease of the sarcomere
25. Dynamic extracellular matrix remodeling in the heart failure: Cardiac hypertrophy, dilatation and fibrosis
26. Role of extracellular matrix metalloproteinases in cardiac remodeling
27. Differential gene expression of extra-cellular matrix components in dilated cardiomyopathy
28. Post-trancriptional regulation of extracellular matrix metalloproteinse in human heart end-stage failure secondary to ischemic cardiomyopathy
29. Homocysteine impairs endocardial endothelial function
30. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
31. Function follows form: Generation of intracellular signals by cell deformation
32. Mutations in the TIMP-3 in patients with Sorsby'dundus dystrophy
33. Task force report on the WHO/ISFC task force on the definition and classification of cardiomyopathies
34. Cardiac defects and renal failure in mice with targeted mutations in Pkd2